Handelsinvest Investeringsforvaltning’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-40,500
Closed -$5.14M 117
2021
Q3
$5.14M Buy
40,500
+8,000
+25% +$1.16M 0.56% 73
2021
Q2
$5.4M Buy
32,500
+12,500
+63% +$2.03M 0.6% 68
2021
Q1
$3.63M Sell
20,000
-19,000
-49% -$4.41M 0.44% 87
2020
Q4
$7.8M Buy
39,000
+14,000
+56% +$2.85M 1.16% 33
2020
Q3
$5.48M Buy
25,000
+3,000
+14% +$635K 1.04% 35
2020
Q2
$4.2M Sell
22,000
-13,000
-37% -$2.28M 0.87% 43
2020
Q1
$5.42M Sell
35,000
-15,000
-30% -$1.75M 1.44% 24
2019
Q4
$4.19M Sell
50,000
-775
-2% -$59K 0.84% 42
2019
Q3
$3.44M Hold
50,775
0.76% 44
2019
Q2
$3.37M Hold
50,775
0.71% 44
2019
Q1
$2.82M Hold
50,775
0.62% 50
2018
Q4
$2.52M Buy
50,775
+30,775
+154% +$1.88M 0.63% 47
2018
Q3
$1.73M Buy
+20,000
New +$1.43M 0.35% 56

Other funds holding TDOC

Handelsinvest Investeringsforvaltning's TDOC Position: Q4 2021 in Review

Handelsinvest Investeringsforvaltning sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 40,500 shares — an estimated $5.14M sold.

Handelsinvest Investeringsforvaltning first reported a position in TDOC in Q3 2018 and held it in 13 quarters. The position peaked at $7.8M in Q4 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Handelsinvest Investeringsforvaltning reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Handelsinvest Investeringsforvaltning sold 40,500 Teladoc Health shares in Q4 2021, an estimated $5.14M.
  • Handelsinvest Investeringsforvaltning first reported a position in Teladoc Health in Q3 2018 and held it in 13 quarters.
  • Handelsinvest Investeringsforvaltning's Teladoc Health position peaked at $7.8M in Q4 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q4 2021, filed 7 Feb 2022.